0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
English
Back
DONATE
  • Patient Videos & Webinars,
• 8/7/24

Module 3: The Potential Promise and Current Challenges of Gene Editing

This module explores advanced gene editing techniques like CRISPR to correct stem cells outside of the body in order to transform 'blue' problematic stem cells into 'green' healthy ones.

It also highlights why current techniques aren’t safe enough for a RUNX1-FPD gene therapy yet.

Previous

Module 2: The Therapeutic Potential of Increasing RUNX1 Activity Using a Drug

Next

Module 4: Banking Stem Cells Today for the Possible Gene Editing Capabilities of Tomorrow

You Might Also Like

Related Embedded Video Item Thumbnail Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML
Related Embedded Video Item Thumbnail Revealing the Genetic Underpinnings of Cytopenias: Navigating the Path to Genetic Testing
Related Embedded Video Item Thumbnail Transcription Factor Associations Fine-Tune Expression of the RUNX1 Gene Network to Confer Regulatory Logic to Hematopoietic Gene Expression Programs
Related Embedded Video Item Thumbnail Nutrition and Cancer: What's The Connection
Related Embedded Video Item Thumbnail Introduction to the Sirolimus Pilot Study (8.9.24)

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP